| 摘要 |
Anti-IL-13 antibodies, crystals of anti-IL-13 antibodies, IL-13 polypeptide/anti-IL-13 antibody complexes, crystals of IL-13 polypeptide/anti-IL-13 antibody complexes, IL-13Ralpha1 polypeptide/IL-13 polypeptide/anti-IL-13 antibody complexes, crystals of IL-13Ralpha1 polypeptide/IL-13 polypeptide/anti-IL-13 antibody complexes, and related methods and software systems are disclosed. |
